| Revenue | NOK 464K | +8549% |
| EBITDA | NOK -5,1M | -11504% |
| Net profit | NOK -5,3M | -10986% |
| Total assets | NOK 1,5M | -54% |
| Equity | NOK -7,3M | -261% |
| Employees | 3 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 199 | 834 | 131 | 5 | 464 |
| Staff expenses | −0 | −0 | −0 | −134 | −3 341 |
| EBITDA | −729 | −287 | −219 | 45 | −5 090 |
| Depreciation & amort. | −42 | −98 | −174 | −72 | −158 |
| EBIT | −771 | −385 | −393 | −27 | −5 248 |
| Net financials | −2 | −4 | −0 | −20 | −5 |
| Profit before tax | −773 | −388 | −394 | −47 | −5 253 |
| Tax | −0 | −88 | −0 | −0 | −0 |
| Net profit | −773 | −300 | −394 | −47 | −5 253 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 631 | 1 971 | 2 930 | 3 358 | 1 539 |
| Equity | −673 | −1 573 | −1 967 | −2 014 | −7 267 |
| Long-term debt | 647 | 2 489 | 3 856 | 5 105 | 8 311 |
| Short-term debt | 657 | 1 056 | 1 040 | 268 | 494 |
| Total debt | 1 304 | 3 544 | 4 896 | 5 372 | 8 805 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CH Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bioconnect As | Company | 100.0% | 100.0% | 2024 |
| Individual | 15.0% | 15.0% | 2023 | |
| Individual | 15.0% | 15.0% | 2023 |
| Person | Role here | Other companies |
|---|---|---|
| Charlotte Hilde Hansson | Chief Executive Officer | 0 companies |
| Bengt Arne Hansson | Chairman | 0 companies |
| Frode Hammer | Chairman | 0 companies |
| Jenny Caroline Hansson | Board of Directors | 0 companies |
| Gjest Andreas Breistein | Chairman | 0 companies |